CT
CVS icon

Caldwell Trust’s CVS Health CVS Stock Holding History

Caldwell Trust’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.5K Sell
517
-63
-11% -$5.62K ﹤0.01% 490
2026
Q1 		$41.7K Sell
580
-50
-8% -$3.85K ﹤0.01% 514
2025
Q4 		$50K Sell
630
-249
-28% -$19.6K ﹤0.01% 485
2025
Q3 		$66.3K Buy
879
+249
+40% +$17.1K 0.01% 433
2025
Q2 		$43.5K Sell
630
-200
-24% -$13.1K ﹤0.01% 483
2025
Q1 		$56.2K Buy
830
+417
+101% +$25K 0.01% 444
2024
Q4 		$18.5K Hold
413
– – ﹤0.01% 558
2024
Q3 		$26K Buy
413
+293
+244% +$17.1K ﹤0.01% 528
2024
Q2 		$7.09K Sell
120
-6,669
-98% -$417K ﹤0.01% 627
2024
Q1 		$541K Sell
6,789
-669
-9% -$51.1K 0.06% 207
2023
Q4 		$589K Sell
7,458
-707
-9% -$50.3K 0.07% 189
2023
Q3 		$570K Sell
8,165
-6,006
-42% -$426K 0.08% 185
2023
Q2 		$980K Buy
14,171
+782
+6% +$55.6K 0.13% 140
2023
Q1 		$995K Buy
13,389
+500
+4% +$41.9K 0.14% 136
2022
Q4 		$1.2M Buy
12,889
+743
+6% +$71.7K 0.17% 122
2022
Q3 		$1.16M Buy
12,146
+624
+5% +$61.8K 0.17% 114
2022
Q2 		$1.07M Buy
11,522
+489
+4% +$47.7K 0.15% 121
2022
Q1 		$1.12M Buy
11,033
+207
+2% +$21.7K 0.13% 135
2021
Q4 		$1.12M Buy
10,826
+315
+3% +$29.1K 0.13% 135
2021
Q3 		$892K Buy
10,511
+919
+10% +$77K 0.11% 143
2021
Q2 		$800K Buy
9,592
+267
+3% +$21.9K 0.1% 150
2021
Q1 		$702K Buy
9,325
+1,538
+20% +$112K 0.1% 153
2020
Q4 		$532K Buy
7,787
+921
+13% +$59.9K 0.08% 168
2020
Q3 		$401K Sell
6,866
-808
-11% -$50.3K 0.07% 187
2020
Q2 		$499K Buy
7,674
+135
+2% +$8.5K 0.08% 174
2020
Q1 		$447K Sell
7,539
-2,319
-24% -$155K 0.08% 166
2019
Q4 		$732K Buy
+9,858
New +$692K 0.11% 146

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Caldwell Trust's CVS Position: Q2 2026 in Review

Caldwell Trust reduced its CVS Health (CVS) stake by 11% in Q2 2026, selling an estimated $5.62K and leaving 517 shares worth $53.5K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Caldwell Trust first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.2M in Q4 2022. 2,070 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Caldwell Trust held 517 shares of CVS Health worth $53.5K as of Q2 2026.
  • Caldwell Trust sold 63 CVS Health shares in Q2 2026, an estimated $5.62K.
  • CVS Health made up ﹤0.01% of Caldwell Trust's portfolio in Q2 2026, its #490 holding.
  • Caldwell Trust first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • Caldwell Trust's CVS Health position peaked at $1.2M in Q4 2022.
  • 2,070 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.